IKENA ONCOLOGY INC (IKNA) Stock Income Statement
NASDAQ:IKNA - Nasdaq - US45175G1085 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 9.16M | 15.62M | 30.99M | 9.19M | |||
| Operating Expenses | 54.55M | 84.58M | 86.52M | 65.12M | 53.71M | |||
| Research and Development | 30.88M | 59.65M | 64.32M | 47.11M | 44.85M | |||
| Selling, General, and Administrative Expenses | 23.68M | 24.93M | 22.20M | 18.02M | 8.87M | |||
| Operating Income | -54.55M | -75.42M | -70.90M | -34.14M | -44.52M | |||
| Interest Income/Expense | 7.37M | 7.11M | 2.15M | N/A | N/A | |||
| Other Income/Expense | 2.52M | -22.00K | -10.00K | 20.00K | 260.00K | |||
| Non Recurring Items | -4.42M | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -49.08M | -68.33M | -68.77M | -34.12M | -44.26M | |||
| Income Tax | 152.00K | -162.00K | N/A | N/A | N/A | |||
| Net Income | -49.23M | -68.17M | -68.77M | -34.12M | -44.26M | |||
| EBITDA | -54.06M | -74.40M | -70.15M | -33.60M | -44.22M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.02 | -1.63 | -1.90 | -0.95 | -1.28 | |||
| Non GAAP EPS | -1.01 | -1.70 | -1.92 | -3.20 | N/A | |||
| Statistics | ||||||||
| Profit Margin | N/A | -744.17% | -440.27% | -110.10% | -481.61% | |||
| Operating Profit Margin | N/A | -823.33% | -453.91% | -110.16% | -484.44% | |||
All data in USD